Mathias Bähr

from Wikipedia, the free encyclopedia
Neurologist and neuroscientist Mathias Bähr

Mathias Bähr (born January 24, 1960 in Mainz ) is a German neurologist and neuroscientist .

Life and career

After graduating from high school in Stuttgart, Mathias Bähr studied human medicine in Tübingen and did his doctorate on a neuropathological topic at the Institute for Brain Research under Jürgen Peiffer . After clinical and scientific training stations at the University Clinic in Düsseldorf (H.-J. Freund), the Max Planck Institute for Developmental Biology in Tübingen (F. Bonhoeffer) and the Washington University in St. Louis (RP Bunge), he was head of a neurobiological-molecular biological working group at the Max Planck Institute for Developmental Biology in Tübingen. He received his specialist training at the Neurological University Clinic in Tübingen, completed his habilitation and worked as senior physician, senior physician and deputy to the clinic director Johannes Dichgans until 2001. Since 2001 he has headed the Department of Neurology at the University Medical Center of the Georg-August University in Göttingen . The clinical and scientific focus is on researching the cellular and molecular basis of de- and regeneration processes in the adult nervous system and the development of new, neuroprotective therapeutic strategies for multiple sclerosis , Parkinson's disease and stroke . He is one of the speakers at the DFG Research Center and Cluster of Excellence Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB). He is the author and co-author of more than 300 scientific publications and Editor in Chief of the journal Molecular and Cellular Neuroscience.

Memberships and offices

Honors and prizes

Fonts (selection)

  • with E. Kilic, GPH Dietz and DM Herrmann (2002): Intravenous TAT-Bcl-XL is protective when delivered before and after middle cerebral artery occlusion in mice. In: Annals of Neurology . 52 (5): 617-22.
  • with Michael Frotscher (2003): Neurological-topical diagnostics: Anatomy - Function - Clinic. 8th edition. Thieme, Stuttgart; 10th edition 2014.
  • with R. Diem, MB Sättler, D. Merkler, I. Demmer, K. Maier, C. Stadelmann and H. Ehrenreich (2005): Combined therapy with methylprednisolone and erythropoietin in a model of multiple sclerosis. In: Brain . 128: 375-85.
  • with Doeppner TR, Bretschneider E, Doehring M, Segura I, Sentürk A, Acker-Palmer A, Hasan MR, Elali A, Hermann DM (2011): Enhancement of endogenous neurogenesis in ephrin-B3 deficient mice after transient focal cerebral ischemia. In: Acta Neuropathologica . 122 (4): 429-42.
  • with Sühs KW, Hein K, Sättler MB, Görlitz A, Ciupka C, Scholz K, Käsmann-Kellner B, Papanagiotou P, Schäffler N, Restemeyer C, Bittersohl D, Hassenstein A, Seitz B, Reith W, Fassbender K, Hilgers R. , Heesen C and Diem R. (2012): A randomized, double-blind, phase 2 study of erythropoietin in optic neuritis. In: Annals of Neurology. Aug; 72 (2): 199-210.

Web links

Individual evidence

  1. ↑ Topic of his dissertation: The importance of perifascicular atrophy in the differential diagnosis of polymyositis.
  2. ^ Neuroscientific Society. Retrieved August 4, 2016 .
  3. ↑ Clinic for Neurology at the University Medical Center Göttingen. Retrieved August 4, 2016 .
  4. ↑ Google Scholar Citations - Mathias Bähr. Retrieved August 26, 2016 .
  5. ^ Molecular and Cellular Neuroscience
  6. ^ Member entry by Mathias Bähr (with picture and CV) at the German Academy of Natural Scientists Leopoldina , accessed on August 22, 2016.
personal data
SURNAME Bähr, Mathias
BRIEF DESCRIPTION German neurologist and neuroscientist
DATE OF BIRTH January 24, 1960
PLACE OF BIRTH Mainz